NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
Acnew study published in Blood Advances demonstrates that patients with haematological...
Chimeric antigen receptor (CAR) T-cell therapy is a highly personalised technology whereby a patient’s...
It is almost 10 years since the 2013 e-health strategy was launched. Kieran Feely examines...
Haematological complications continue to represent a major source of morbidity and mortality during
Maternal death is no longer one of the specified serious adverse events under the remit of...
No “definitive model” has been agreed for a clinical pathway for head-injured patients in the new...
The new HSE technology and transformation committee has described as “unfavourable” the...
The HSE has confirmed to the Medical Independent (MI) that a market soundings process is...
Documents have revealed some resistance to full engagement with a HSE obstetric event support team...
Data from an ongoing study of the GP access to diagnostics programme will show that it...
A national breast implant registry will be developed over the next two years, the HSE has...
Patient frustration due to healthcare capacity deficits is manifesting in aggression towards GP...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT